IBT
AMRN

International Biotechnology Trust’s Amarin Corp AMRN Stock Holding History

International Biotechnology Trust’s Portfolio AMRN Stock Details AMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-16,000
Closed -$1.27M – 55
2020
Q1 		$1.27M Sell
16,000
-3,400
-18% -$1.13M 0.58% 31
2019
Q4 		$8.31M Buy
19,400
+6,450
+50% +$2.45M 3% 13
2019
Q3 		$3.93M Buy
12,950
+6,100
+89% +$2.13M 1.81% 17
2019
Q2 		$2.65M Hold
6,850
– – 0.98% 26
2019
Q1 		$2.84M Buy
6,850
+2,850
+71% +$1.03M 1.05% 32
2018
Q4 		$854K Buy
+4,000
New +$1.46M 0.53% 34

Other funds holding AMRN

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

International Biotechnology Trust's AMRN Position: Q2 2020 in Review

International Biotechnology Trust sold out of Amarin Corp (AMRN) in Q2 2020, closing a stake of 16,000 shares — an estimated $1.27M sold.

International Biotechnology Trust first reported a position in AMRN in Q4 2018 and held it in 6 quarters. The position peaked at $8.31M in Q4 2019. 283 funds tracked by Wall St. Rank hold AMRN as of Q2 2020.

  • International Biotechnology Trust reported no remaining Amarin Corp position as of Q2 2020 after selling out during the quarter.
  • International Biotechnology Trust sold 16,000 Amarin Corp shares in Q2 2020, an estimated $1.27M.
  • International Biotechnology Trust first reported a position in Amarin Corp in Q4 2018 and held it in 6 quarters.
  • International Biotechnology Trust's Amarin Corp position peaked at $8.31M in Q4 2019.
  • 283 funds tracked by Wall St. Rank held Amarin Corp as of Q2 2020.

Based on International Biotechnology Trust's 13F filing for Q2 2020, filed 14 Jul 2020.